Acidic polysaccharide isolated from Phellinus linteus induces nitric oxide-mediated tumoricidal activity of macrophages through protein tyrosine kinase and protein kinase C

Biochemical and Biophysical Research Communications

Volumn 309, Issue 2, 2003, Pages 399-407

  Kim, Gi Young ^a   Oh, Yang Hyo ^b   Park, Yeong Min ^b,c  

^a Pusan National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Dong A University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; GENISTEIN; IMMUNOMODULATING AGENT; NITRIC OXIDE; POLYSACCHARIDE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; STAUROSPORINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; FEMALE; MACROPHAGE ACTIVATION; MOUSE; MUSHROOM; NONHUMAN; PHELLINUS LINTEUS;

BASIDIOMYCOTA; INONOTUS LINTEUS; MURINAE; PHELLINUS; PHELLINUS LINTEUS;

EID: 0042925519     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.018     Document Type: Article

References (48)

1. Kim G.Y., Park H.S., Nam B.H., Lee S.J., Lee J.D. Purification and characterization of acidic proteo-heteroglycan from the fruiting body of Phellinus linteus (Berk. & M. A. Curtis) Teng. Biores. Technol. 87:2003;81-87.
2. Han S.B., Lee C.W., Jeon Y.J., Hong N.D., Yoo I.D., Yang K.H., Kim H.M. The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis. Immunopharmacology. 41:1999;157-164.
3. Kim H.M., Han S.B., Oh G.T., Kim Y.H., Hong D.H., Hong N.D., Yoo I.D. Stimulation of humoral and cell mediated immunity by polysaccharide from mushroom Phellinus linteus. Int. J. Immunopharmacol. 18:1996;295-303.
4. Hahn H., Kaufmann S.H.E. The role of cell-mediated immunity in bacterial infections. Rev. Infect. Dis. 3:1981;1221-1250.
5. Verstovsek S., Maccubbin D., Mihich E. Tumoricidal activation of murine resident peritoneal macrophage by interleukin 2 and tumor necrosis factor. Cancer Res. 52:1992;3880-3885.
6. Fidler I.J., Kleinerman E.S. Therapy of cancer metastasis by systemic activation of macrophages; from bench to the clinic. Res. Immunol. 144:1993;274-276.
7. Zirk N.M., Hashmi S.F., Ziegler H.K. The polysaccharide portion of lipopolysaccharide regulates antigen-specific T-cell activation via effects on macrophage-mediated antigen processing. Infect. Immun. 67:1999;319-326.
8. Stuehr D.J., Marletta M.A. Synthesis of nitrite and nitrate in macrophage cell lines. Cancer Res. 47:1987;5590-5594.
9. Choriki M., Freudenberg M., Calanos C., Poindrom P., Bartholeyns J. Antitumoral effects of lipopolysaccharide, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution. Anticancer Res. 9:1989;1185-1190.
10. Keller R., Keist R., Frei K. Lymphokines and bacteria that induce tumoricidal activity, trigger a different secretary response in macrophages. Eur. J. Immunol. 20:1990;690-698.
11. Adachi Y., Okazaki M., Ohno N., Yadamae Y. Enhancement of cytokine production by macrophages stimulated with. (1→3 )-β-glucan, Grifolan (GRN), isolated from Grifola frondosa Biol. Pharm. Bull. 17:1994;1554-1560.
12. Vilcek J., Lee T.H. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266:1991;7313-7316.
13. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., Murphy W.J. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 90:1993;9730-9734.
14. Nathan C.F. Secretory products of macrophages. J. Clin. Invest. 79:1987;319-326.
15. Lowenstein C.J., Dinerman J.L., Snyder S.H. Nitric oxide: a physiologic messenger. Ann. Intern. Med. 120:1994;227-237.
16. Duerksen-Hughes P.J., Day D., Laster S.M., Zachariades N.A., Aquino L., Gooding L.R. Both tumor necrosis factor and nitric oxide participate in lysis of simian virus 40-transformed cells by activated macrophages. J. Immunol. 149:1992;2114-2122.
17. Lorsbach R.B., Murphy W.J., Lowenstein C.J., Snyder S.H., Russell S.W. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J. Biol. Chem. 268:1993;1908-1913.
18. Stuehr D.J., Nathan C.F. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cell. J. Exp. Med. 169:1989;1543-1555.
19. Farias-Eisner R., Sherman M.P., Aerberhard E., Chaudhuri G. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl. Acad. Sci. USA. 91:1994;9407-9411.
20. Gupta D., Jin Y., Dziarski R. Peptidoglycan induces transcription and secretion of TNF-α and activation of Lyn, extracellular signal-regulated kinase, and Rsk signal transduction proteins in mouse macrophages. J. Immunol. 155:1995;2620-2630.
21. Dong Z., O'Brian C.A., Fidler I.J. Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine kinase activity. J. Leukocyte Biol. 53:1993;53-60.
22. Um S.H., Rhee D.K., Pyo S.K. Involvement of protein kinase C and tyrosine kinase in tumoricidal activation of macrophage induced by Streptococcus pneumoniae type II capsular polysaccharide. Int. Immunopharmacol. 5:1993;1119-1128.
23. Doherty D.G., O'Farrelly C. Innate and adaptive lymphoid cells in the human lever. Immunol. Rev. 174:2000;5-20.
24. Ross G.D., Větvička V. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin. Exp. Immunol. 92:1993;181-184.
25. Renzo L.D., Yefenof E., Klein E. The function of human NK cells is enhanced by β-glucan, a ligand of CR3 (CD11b/CD18). Eur. J. Immunol. 21:1991;1755-1758.
26. Thornton B.P., Větvička V., Pitman M., Goldman R.C., Ross G.D. Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156:1996;1235-1246.
27. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:1995;389-400.
28. Noorman F., Barett-Bergshoeff M.M., Bekkers M., Emeis J.J., Rijken D.C. Inhibition of mannose receptor-mediated clearance of tissue-type plasminogen activator (t-PA) by dextran: a new explanation for its antithrombotic effect. Thromb. Haemastasis. 78:1997;1249-1254.
29. Taguchi T., Furue H., Kimura T., Kondo T., Hattori T., Itoh I., Ogawa N. Endo-point results of phase III study of lentinan. Jpn. J. Cancer Chemother. 12:1985;366-378.
30. Okamura K., Suzuki M., Chihara T., Fujiwara A., Fukuda T., Goto S., Ichinohe K., Jimi S., Kasamatsu T., Kawai N.et al. Clinical evaluation of Shizophyllan combined with irradiation in patients with cervical cancer. A randomized controlled study. Cancer. 58:1986;865-872.
31. Kim G.Y., Park S.K., Lee M.K., Lee S.H., Oh Y.H., Kwak J.Y., Yoon S., Lee J.D., Park Y.M. Proteoglycan isolated from Phellinus linteus activates murine B lymphocytes via protein kinase C and protein tyrosine kinase. Int. Immunopharmacol. 506:2003;1281-1292.
32. Lichtenfels R., Biddison W.E., Schulz H., Vogt A.B., Martin R. CARE-LASS (calcein-release assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J. Immunol. Methods. 172:1994;227-239.
33. Cho J.H., Cho S.D., Hu H., Kim S.H., Lee S.K., Lee Y.S., Kang K.S. The roles of ERK1/2 and p38 MAP kinases in the preventive mechanisms of mushroom Phellinus linteus against the inhibition of gap junctional intercellular communication by hydrogen peroxide. Carcinogenesis. 23:2002;1163-1169.
34. Hibbs J.B. Jr., Taintor R.R., Vavrin Z. Macrophage cytotoxicity: role for L-arginine deaminase and imino nitrogen oxidation to nitrite. Science. 235:1987;473-476.
35. MacMicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., Stevens K., Xie Q.W., Sokol K., Hutchinson N.et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:1995;641-650.
36. Yim C.Y., Bastian N.R., Smith J.C., Hibbs J.B. Jr., Samlowski W.E. Macrophage nitric oxide synthesis delays progression of ultraviolet light-induced murine skin cancers. Cancer Res. 53:1993;5507-5511.
37. Farias-Eisner R., Sherman M.P., Aeberhard E., Chaudhuri G. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl. Acad. Sci. USA. 91:1994;9407-9411.
38. Xie K., Huang S., Dong Z., Juang S.H., Gutman M., Xie Q.W., Nathan C., Fidler I.J. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181:1995;1333-1343.
39. Goenka S., Das T., Sa G., Ray P.K. Protein A induces no production: involvement of tyrosine kinase, phospholipase c, and protein kinase C. Biochem. Biophys. Res. Commun. 250:1998;425-429.
40. Peter-Golden M., McNish R.W., Sporn P.H., Balazovich K. Basal activation of protein kinase C in rat alveolar macrophages: implications for arachidonate metabolism. Am. J. Physiol. 261:1991;462-471.
41. Shishodia S., Shrivastava A., Sodhi A. Protein kinase C: a potential pathway of macrophage activation with cisplatin. Immunol. Lett. 61:1998;179-186.
42. Zhang J., Tang Q., Zimmerman-Kordmann M., Reutter W., Fan H. Activation of B lymphocytes by GLIS, a bioactive proteoglycan from Ganoderma lucidum. Life Sci. 71:2002;623-638.
43. Czop J.K., Kay J. Isolation and characterization of β-glucan receptors on human mononuclear phagocytes. J. Exp. Med. 173:1991;1511-1520.
44. Zimmerman J.W., Lindermuth J., Fish P.A., Palace G.P., Stevenson T.T., DeMong D.E. A novel carbohydrate-glycosphingolipid interaction between a β-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J. Biol. Chem. 273:1999;22014-22020.
45. Xia Y., Větvička V., Yan J., Hanikyrova M., Mayadas T.N., Ross G.D. The β-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J. Immunol. 162:1999;2281-2290.
46. Petty H.R., Todd R.F. Receptor-receptor interactions of complement receptor type 3 in neutrophil membranes. J. Leukocyte Biol. 54:1993;492-494.
47. Brown E., Hogg N. Where the outside meets the inside: integrins as activators and targets of signal transduction cascades. Immunol. Lett. 54:1996;189-193.
48. Newton R.A., Thiel M., Hogg N. Signaling mechanisms and the activation of leukocyte integrins. J. Leukocyte Biol. 61:1997;422-426.